Navigation Links
DNA Genotek Inc. Announces $10,000 GenoFIND™ Genomic Services Award
Date:2/6/2013

Ottawa, ON (PRWEB) February 06, 2013

DNA Genotek, a leading provider of products for biological sample collection, today announced that it is introducing the GenoFIND Genomic Services Award, which is designed to facilitate analysis of nucleic acid samples. The award will accelerate genetic discoveries by providing $10,000 US in GenoFIND services to the selected winner. GenoFIND is a compilation of commercially available genomic services that include: nucleic acid extraction, SNP genotyping, PCR-based assays, whole genome and targeted sequencing, array-based SNP and expression profiling, custom assay development and bioinformatic analysis.

DNA Genotek is accepting award entries from researchers at academic institutions and non-profit research centers from now until March 1, 2013. The winner will be notified on March 12, 2013. Requirements for submission include a brief abstract of the research project, the number and type of collected samples, and the type of assays required for analysis.

“We designed this award to recognize and reward researchers who have collected nucleic acid samples and are ready to analyze those samples,” said Ian Curry, president of DNA Genotek Inc. “We are pleased to be able to provide genomic analysis services and research-ready data that can immediately be used to help researchers gain insights into a disease or condition.”

For more information about the award or to submit an entry, please visit http://www.dnagenotek.com/US/genofind-award/

About DNA Genotek

DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), focuses on providing high-quality biological sample collection, stabilization and preparation products. The company’s Oragene®.Dx product line is the only FDA 510(k) cleared saliva-based collection kit for in vitro diagnostic use. DNA Genotek also offers Research Use Only products to collect and preserve large amounts of DNA or RNA from saliva for use with humans, animals or livestock. The reliability and ease-of-use of the company’s products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has a global customer base with thousands of customers in over 100 countries. For more information about DNA Genotek, visit http://www.dnagenotek.com

® Oragene is a registered trademark and GenoFIND is a trademark of DNA Genotek Inc. All other brands and names contained herein are the property of their respective owners. Some DNA Genotek products may not be available in all geographic regions.

###

Read the full story at http://www.prweb.com/releases/2013/2/prweb10398537.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... , ... Having proven that its Disruptor™ technology is more ... Green Cell Technologies® (GCT®), has turned its attention to the lucrative fruit ... methods, ushering in a new era of modern, cost effective and more natural ...
(Date:8/22/2017)... ... 22, 2017 , ... Cutting Edge Spine , a ... spinal implant technologies, announced today the appointment of Luke Maher as Director U.S. ... experience to directing Cutting Edge Spine’s national sales force, including 12+ years at ...
(Date:8/21/2017)... Kamuela/Waimea (PRWEB) , ... August 21, 2017 , ... ... based on the Big Island of Hawaii, is pleased to announce the first ... Trudeau, R(S) of MacArthur Sotheby’s International Realty is working together with listing agent ...
(Date:8/21/2017)... , ... August 21, 2017 , ... ... two speakers for this two-part educational webinar, in which attendees will learn about ... associated protein factor composition. Along with an overview of the development and validation ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):